Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers? (original) (raw)

Minireviews

Copyright ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.

World J Gastroenterol. Sep 28, 2018; 24(36): 4152-4163
Published online Sep 28, 2018. doi: 10.3748/wjg.v24.i36.4152

Table 2 Predictive and/or prognostic value of biological markers in hepatocellular carcinoma patients

Biological markers Predictive value Prognostic value Ref.
Serum and plasma proteins
VEGF-A No Uncertain [4,57]
Ang-2 No Yes [4]
IGF-1 No No [55]
Single nucleotide polymorphisms
VEGF-A rs2010963 No Yes [65]
VEGF-C rs4604006 No Yes [65]
eNOS (_eNOS_-786/eNOS VNTR) No Yes [66]
Ang-2 rs55633437 No Yes [67]
HIF-1 alpha rs12434438 No Yes [68]
Amplifications
VEGF No Uncertain [70]
FGF3/FGF4 No Uncertain [71]
miRNAs
miR-425-3p No Yes [74]
miR-224 No Yes [75]
miR-181a-5p No Yes [77]
miR-339-5p No Yes [77]
miR-423-5p No Yes [78]
miR-10b-3p No Yes [79]
miR-221 No Uncertain [76]
Tissue biomarker expression
Phospho-ERK Uncertain Uncertain [81,82]
PDGFR-b No Yes [84]
c-Met No No [84]
VEGFR No No [84]
p-c-Jun No Yes [85]